|Application ||WB, FC, IHC-P, E|
|Calculated MW||72661 Da|
|Antigen Region||456-484 aa|
|Other Names||Tumor necrosis factor alpha-induced protein 2, TNF alpha-induced protein 2, Primary response gene B94 protein, TNFAIP2|
|Target/Specificity||This TNFAIP2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 456-484 amino acids from the Central region of human TNFAIP2.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||TNFAIP2 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||May play a role as a mediator of inflammation and angiogenesis.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
TNFAIP2 expression can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells. The expression of TNFAIP2 was shown to be induced by retinoic acid in a cell line expressing a oncogenic version of the retinoic acid receptor alpha fusion protein, which suggested that its gene may be a retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak,M.E., Cancer Res. 60 (7), 1824-1829 (2000)
If you have any additional inquiries please email technical services at email@example.com.